Chris Ware

Chris Ware is an Associate Principal Scientist at Merck, specializing in the development and execution of complex histology-based assays for neurodegeneration programs, as well as previous work in oncology, respiratory, and immunology. Prior to this, Chris held positions as a Senior Scientist and Associate Scientist at Merck, contributing to various research initiatives. Chris began their career as a Senior Research Associate at Repligen Corporation, focusing on the effects of the gastrointestinal peptide Secretin on brain activity. They hold a Bachelor of Science degree in Pre-Veterinary studies from the University of New Hampshire.